MedTrace Logo

Study of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner

NCT01372501 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2017-02-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether the GI Endobarrier Liner can be reimplanted.

Conditions

Interventions

DEVICE

Endobarrier Liner

Medical device placed endoscopically in the duodenum

Sponsors & Collaborators

  • Morphic Medical Inc.

    lead INDUSTRY

Principal Investigators

  • Alex P Escalona, MD · Pontificia Universidad Catolica de Chile, Santiago, Chile

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-11-30
Completion
2012-09-30

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01372501 on ClinicalTrials.gov